Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on single cell multiomics market provides in-depth analysis of segments and sub-segments in the global as well as regional single cell multiomics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional single cell multiomics market over the short term as well as the long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global single cell multiomics market. According to the report, the global single cell multiomics market is projected to grow at a CAGR of nearly 18% over the forecast period of 2022-2028.
The global single cell multiomics market was valued at about USD 3.5 Billion in 2022 and is expected to reach nearly USD 9.5 Billion in 2028, with a CAGR of nearly 18% during the forecast period. The single cell multiomics technologies include multiple types of molecules from the same individual cell, allowing for more in-depth biological insight—such biological insights by analyzing each molecular layer from separate cells. By using single cell multiomics technologies, multiple modalities from the same cell can be measured. Furthermore, the measurements can be done using processes like DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, spatial information, and others. Moreover, the individual omics data is combined sequentially or simultaneously by integrated techniques for understanding the interplay of molecules. These single cell sequencing technologies can be classified as genotypic and phenotypic; both of these helps in determining the mechanisms that govern diseases and health. Additionally, the application of single cell multiomics is in oncology, cell biology, neurology, stem cell, immunology, and others. Single cell multiomics are a powerful tool used in virology because they have enormous potential for deciphering virus biology and virus-host cell interactions. Such virology will be used more frequently in the coming days.
The technological advancements in single cell analysis products and the rise in the number of large-scale genomics studies leveraging single-cell RNA Sequencing are the prime factors driving the market’s growth during the forecast period. Furthermore, due to rising disposable income in emerging nations and increasing adoption of personalized medicine for screening and diagnostics of genetic disorders, there is a rise in the growth of the single cell multiomics market. Additionally, there is increased interest among researchers in the field of single cell genomics due to new single cell platforms facilitating separation and analysis, and both the potential development and limitations of these technologies are rapidly developing. Such technological advancements can propel the market’s growth during the forecast period. However, the market’s growth is hampered by factors like the high cost of single cell analysis and the scarcity of ample online data storage and analysis platforms. Nevertheless, increased collaborations and funding in single cell multiomics research and expansion into new research applications, such as singlecell metabolomics, are projected to provide lucrative growth opportunities to singlecell multiomics market players.
North America is expected to earn the largest revenue share in the market, and hence the region can dominate the market during the forecast period. The availability of developed healthcare infrastructure and continuous research activities to develop advanced technologies are the essential factors that are anticipated to witness growth in the region. Furthermore, Europe is the second dominating market region because it holds the second-largest share after North America. The countries like Germany and UK are expected to grow at a high CAGR in Europe's singlecell multiomics market during the forecast period.
The report on the global single cell multiomics market covers segments such as type, application, technique, and end user. On the basis of type, the sub-markets include single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. On the basis of application, the sub-markets include oncology, cell biology, neurology, immunology, and stem cell research. On the basis of technique, the sub-markets include single-cell isolation & dispensing, and single-cell analysis. On the basis of end user, the sub-markets include academic institutes, contract research organizations, and pharmaceutical & biotech companies.
The report provides profiles of the companies in the market such as 10x Genomics, Inc., Becton, Dickinson and Company, Berkeley Lights Inc., BGI Genomics Co. Ltd, Bio Rad Laboratories, Inc., Danaher Corporation (Cytiva Life Sciences), Dolomite Bio, Illumina, Inc, Epicypher Inc., and Mission Bio, Inc.
The report provides deep insights
into demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of single cell multiomics market. Moreover, the study highlights
current market trends and provides forecast from 2022-2028. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players.
Please Choose One of them.